Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 243

1.

ECG quantification of myocardial scar and risk stratification in MADIT-II.

Loring Z, Zareba W, McNitt S, Strauss DG, Wagner GS, Daubert JP.

Ann Noninvasive Electrocardiol. 2013 Sep;18(5):427-35. doi: 10.1111/anec.12065. Epub 2013 Jun 9.

2.

Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2005;5(14):1-74. Epub 2005 Sep 1.

3.

An ECG index of myocardial scar enhances prediction of defibrillator shocks: an analysis of the Sudden Cardiac Death in Heart Failure Trial.

Strauss DG, Poole JE, Wagner GS, Selvester RH, Miller JM, Anderson J, Johnson G, McNulty SE, Mark DB, Lee KL, Bardy GH, Wu KC.

Heart Rhythm. 2011 Jan;8(1):38-45. doi: 10.1016/j.hrthm.2010.09.071. Epub 2010 Sep 25.

4.

Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).

Dhar R, Alsheikh-Ali AA, Estes NA 3rd, Moss AJ, Zareba W, Daubert JP, Greenberg H, Case RB, Kent DM.

Heart Rhythm. 2008 Jun;5(6):807-13. doi: 10.1016/j.hrthm.2008.02.013. Epub 2008 Feb 16.

5.

Can QRS scoring predict left ventricular scar and clinical outcomes?

Rosengarten JA, Scott PA, Chiu OK, Shambrook JS, Curzen NP, Morgan JM.

Europace. 2013 Jul;15(7):1034-41. doi: 10.1093/europace/eut014. Epub 2013 Mar 14.

6.

ECG quantification of myocardial scar in cardiomyopathy patients with or without conduction defects: correlation with cardiac magnetic resonance and arrhythmogenesis.

Strauss DG, Selvester RH, Lima JA, Arheden H, Miller JM, Gerstenblith G, Marbán E, Weiss RG, Tomaselli GF, Wagner GS, Wu KC.

Circ Arrhythm Electrophysiol. 2008 Dec;1(5):327-36. doi: 10.1161/CIRCEP.108.798660. Epub 2008 Dec 2.

7.

QRS fragmentation and the risk of sudden cardiac death in MADIT II.

Brenyo A, Pietrasik G, Barsheshet A, Huang DT, Polonsky B, McNitt S, Moss AJ, Zareba W.

J Cardiovasc Electrophysiol. 2012 Dec;23(12):1343-8. doi: 10.1111/j.1540-8167.2012.02390.x. Epub 2012 Jul 16.

PMID:
22805297
8.

Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death?

Dagres N, Hindricks G.

Eur Heart J. 2013 Jul;34(26):1964-71. doi: 10.1093/eurheartj/eht109. Epub 2013 May 3. Review.

9.

ECG quantification of myocardial scar does not differ between primary and secondary prevention ICD recipients with ischemic heart disease.

Kraaier K, van Dessel PF, van der Palen J, Wilde AA, Scholten MF.

Pacing Clin Electrophysiol. 2010 Feb;33(2):192-7. doi: 10.1111/j.1540-8159.2009.02611.x. Epub 2009 Nov 4.

PMID:
19889190
10.

New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.

Klein H, Auricchio A, Reek S, Geller C.

Am J Cardiol. 1999 Mar 11;83(5B):91D-97D. Review.

PMID:
10089848
11.

ECG marker of adverse electrical remodeling post-myocardial infarction predicts outcomes in MADIT II study.

Tereshchenko LG, McNitt S, Han L, Berger RD, Zareba W.

PLoS One. 2012;7(12):e51812. doi: 10.1371/journal.pone.0051812. Epub 2012 Dec 14.

12.

Differences in outcomes between patients treated with single- versus dual-chamber implantable cardioverter defibrillators: a substudy of the Multicenter Automatic Defibrillator Implantation Trial II.

Berenbom LD, Weiford BC, Vacek JL, Emert MP, Hall WJ, Andrews ML, McNitt S, Zareba W, Moss AJ.

Ann Noninvasive Electrocardiol. 2005 Oct;10(4):429-35.

PMID:
16255753
13.

Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.

Bloomfield DM, Steinman RC, Namerow PB, Parides M, Davidenko J, Kaufman ES, Shinn T, Curtis A, Fontaine J, Holmes D, Russo A, Tang C, Bigger JT Jr.

Circulation. 2004 Oct 5;110(14):1885-9. Epub 2004 Sep 27.

14.

Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.

Bellocci F, Biasucci LM, Gensini GF, Padeletti L, Raviele A, Santini M, Giubilato G, Landolina M, Biondi-Zoccai G, Raciti G, Sassara M, Castro A, Kheir A, Crea F.

J Cardiovasc Med (Hagerstown). 2007 Apr;8(4):293-9.

PMID:
17413310
15.

Early echocardiographic deformation analysis for the prediction of sudden cardiac death and life-threatening arrhythmias after myocardial infarction.

Ersbøll M, Valeur N, Andersen MJ, Mogensen UM, Vinther M, Svendsen JH, Møller JE, Kisslo J, Velazquez EJ, Hassager C, Søgaard P, Køber L.

JACC Cardiovasc Imaging. 2013 Aug;6(8):851-60. doi: 10.1016/j.jcmg.2013.05.009. Epub 2013 Jul 10.

16.

Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.

Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, Zareba W, McNitt S, Andrews ML; MADIT-II Investigators.

J Am Coll Cardiol. 2008 Jan 22;51(3):288-96. doi: 10.1016/j.jacc.2007.08.058.

17.

Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II).

Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML; MADIT-II Investigators.

J Am Coll Cardiol. 2004 Apr 21;43(8):1459-65.

18.

Effect of left ventricular ejection fraction and QRS duration on the survival benefit of implantable cardioverter-defibrillators: meta-analysis of primary prevention trials.

Katritsis DG, Siontis KC, Bigger JT, Kadish AH, Steinman R, Zareba W, Siontis GC, Bardy GH, Ioannidis JP.

Heart Rhythm. 2013 Feb;10(2):200-6. doi: 10.1016/j.hrthm.2012.10.039. Epub 2012 Oct 27. Review.

PMID:
23107652
19.

Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

Piccini JP, Al-Khatib SM, Hellkamp AS, Anstrom KJ, Poole JE, Mark DB, Lee KL, Bardy GH.

Heart Rhythm. 2011 Mar;8(3):393-400. doi: 10.1016/j.hrthm.2010.11.033. Epub 2010 Nov 23.

20.

Predictive value of fragmented QRS in primary prevention implantable cardioverter defibrillator recipients with left ventricular dysfunction.

Forleo GB, Della Rocca DG, Papavasileiou LP, Panattoni G, Sergi D, Duro L, Mahfouz K, Magliano G, Santini L, Romeo F.

J Cardiovasc Med (Hagerstown). 2011 Nov;12(11):779-84. doi: 10.2459/JCM.0b013e32834ae458.

PMID:
21941203
Items per page

Supplemental Content

Write to the Help Desk